TrianglePUBLICATIONS · 11870177
Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2002 Mar 1
- First author
- Socinski MA
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Socinski MA
- type
- Author
- name
- Schell MJ
- type
- Author
- name
- Peterman A
- type
- Author
- name
- Bakri K
- type
- Author
- name
- Yates S
- type
- Author
- name
- Gitten R
- type
- Author
- name
- Unger P
- type
- Author
- name
- Lee J
- type
- Author
- name
- Lee JH
- type
- Author
- name
- Tynan M
- type
- Author
- name
- Moore M
- type
- Author
- name
- Kies MS
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Socinski MA
- type
- Author
- name
- Schell MJ
- type
- Author
- name
- Peterman A
- type
- Author
- name
- Bakri K
- type
- Author
- name
- Yates S
- type
- Author
- name
- Gitten R
- type
- Author
- name
- Unger P
- type
- Author
- name
- Lee J
- type
- Author
- name
- Lee JH
- type
- Author
- name
- Tynan M
- type
- Author
- name
- Moore M
- type
- Author
- name
- Kies MS
- type
- Author
- bibliography ids
- nci-bib-9431bde81de433089e19ddac
- book metadata
- content sha256
- 3b02975e47c16f3e2774ee526b92ed1732d83145f55da25fc955233274200756
- document type
- citation
- dois
- 10.1200/JCO.2002.20.5.1335
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:11870177
- immutable id
- pubmed:11870177@3b02975e47c16f3e2774ee526b92ed1732d83145f55da25fc955233274200756
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 5
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1335-43
- volume
- 20
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 11870177
- provenance
- batch id
- d4e82e28940c878dd0a2
- provider
- NCBI PubMed ESummary
- record sha256
- 685b4e23c90f1106198ed94eda850284802fd38f8090a1d05755358e593a5cf9
- response sha256
- 257c7530b1505623f6712628a73c1e9b8b3119838f4ec701e62de2dab9d87468
- retrieved at
- 2026-09-09T23:45:44.017762+00:00
- publication date
- display
- 2002 Mar 1
- precision
- day
- year
- 2002
- publication types
- Clinical Trial
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer.
Preserved source evidence · Not medical advice